Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Oxytetracycline Action Pathway
Homo sapiens
Drug Action Pathway
Created: 2013-08-22
Last Updated: 2019-08-16
Oxytetracycline, the second of the tetracyclines discovered, is a broad-spectrum antibiotic. Oxytetracycline is lipophilic and easily passes through cell membranes or enters bacterial cells via membrane porin channels. Once inside the cell, it binds to the bacterial 30S ribosomal subunit and prevents aminoacyl tRNA from binding to the A site of the ribosome-RNA complex; binding inhibition likely occurs through steric hindrance. The overall effect is inhibition of bacterial protein synthesis and hence growth.
References
Oxytetracycline Pathway References
[http://www.drugbank.ca](http://www.drugbank.ca/drugs/DB00595)
Song, K.S. Ribosomal protein synthesis inhibitors. In S. Offermanns, & W. Rosenthal (Eds.). Encyclopedic reference of molecular pharmacology. (2004) p. 827-833. Berlin, Germany: Springer.
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
No Proteins Present
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
No Proteins Present
Settings